The Women's Health - Menopause project, initiated on October 1, 2023, is a 36-month investigative study designed to explore the various stages of menopause. The objective is to delineate each phase and to observe biomarker fluctuations during transitions from the perimenopause stage to post-menopause.Furthermore, the research aims to examine the alterations in biomarkers and biometrics in response to different menopausal treatments, including hormone therapies. BioTwin is focused on providing insights that could contribute to the scientific community's understanding of menopause, with the ultimate goal being the development of future strategies tailored to individual profiles. We invite researchers and participants interested in this area of women's health to collaborate and share insights. Your contribution is invaluable to the advancement of this scientific inquiry.
Women's Health - Menopause
The Women's Health - Menopause project, initiated on October 1, 2023, is a 36-month investigative study designed to explore the various stages of menopause. The objective is to delineate each phase and to observe biomarker fluctuations during transitions from the perimenopause stage to post-menopause.Furthermore, the research aims to examine the alterations in biomarkers and biometrics in response to different menopausal treatments, including hormone therapies. BioTwin is focused on providing insights that could contribute to the scientific community's understanding of menopause, with the ultimate goal being the development of future strategies tailored to individual profiles. We invite researchers and participants interested in this area of women's health to collaborate and share insights. Your contribution is invaluable to the advancement of this scientific inquiry.
About This Research
Research Objective
To understand and improve outcomes for women's health.
Expected Outcomes
- Profile all phases of Menopause.
- Track biomarkers during stage transitions.
- Monitor the effects of different menopause treatments, such as hormone therapy.